MiR-15b-5p Promotes Growth and Metastasis of Renal Clear Cell Carcinoma

DOI :
Tweet about this on TwitterShare on FacebookEmail this to someoneShare on Google+

Xing Bi; Mengzhen Tian & Peng Chen

Summary

We investigated the expression and clinical significance of miR-15b-5p in clear cell renal cell carcinoma (RCC) through bioinformatics analysis and experimental verification. The differentially expressed miRNAs were screened in the GEO database. Venn diagram showed that there were 5 up-regulated miRNAs (has-miR-210, has-miR-142-3p, has-miR-142-5p, has-miR-15b-5p, and has-miR-193a-3p) and only 1 down-regulated miRNA (has-miR-532-3p) that were commonly expressed between GSE189331 and GSE16441 datasets. This was further confirmed in TCGA. Further analysis showed that the has-miR-193a-3p, has-miR-142-3p, has- miR-142-5p, and has-miR-15b-5p were closely related to tumor invasion, distant metastasis and survival probability. The expression of miR-15b-5p in ccRCC tissues was significantly higher than that in adjacent normal kidney tissues (P<0.05). The expression of miR-15b- 5p had no significant relationship with gender, age, smoking history, body mass index, T stage and pathological nuclear grade (P>0.05). Following inhibition of miR-15b-5p expression, RCC cells had attenuated proliferation, increased apoptosis, and attenuated migration and invasion. has-miR-15b-5p-WEE1, has-miR-15b-5p-EIF4E, has-miR-15b-5p-PPP2R1B may be three potential regulatory pathways in ccRCC. miR-15b-5p is highly expressed in cancer tissues of ccRCC patients. It may promote proliferation, inhibit apoptosis and enhance cell migration and invasion of RCC cells. The has-miR-15b-5p-WEE1, has-miR-15b-5p-EIF4E, and has-miR-15b-5p-PPP2R1B may be three potential regulatory pathways in ccRCC.

KEY WORDS: MicroRNA; Clear cell renal cell carcinoma; Real-time PCR; Spread; Migration; Bioinformatics analysis.

How to cite this article

BI,X.;TIAN,M.&CHEN,P. MiR-15b-5ppromotesgrowthandmetastasisofrenalclearcellcarcinoma. Int.J.Morphol.,41(6):1789- 1801, 2023.